Dietary zinc modulation of COX-2 expression and lingual and esophageal carcinogenesis in rats

被引:61
作者
Fong, LYY
Zhang, L
Jiang, YB
Farber, JL
机构
[1] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA
关键词
D O I
10.1093/jnci/dji006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Cancer of the upper aerodigestive tract, including esophageal and tongue carcinomas, is a major cause of cancer deaths worldwide. Esophageal and tongue cancers have both been associated with dietary zinc deficiency (ZD), and cyclooxygenase (COX-2) is often overexpressed in these cancers. Using rat models, we examined whether zinc regulates COX-2 expression in these cancers. Method: Expression of COX-2 protein and mRNA in rat lingual and esophageal epithelia in control (zinc sufficient [ZS]) rats, during ZD, and after intragastric zinc replenishment (ZR) were determined by immunoblotting, immunohistochemistry, and real-time quantitative polymerase chain reaction. COX-2 gene expression, cell proliferation, and apoptosis were analyzed in ZD, ZR, and ZD rats treated with the COX-2 inhibitors celecoxib and indomethacin. Tumor development in ZD rats treated by continuous exposure to the carcinogen 4-nitroquinoline 1 oxide (NQO), which causes tongue tumors in rats, was compared with those in NQO-treated ZS rats. Statistical tests were two-sided. Results: The esophagus and tongue of ZD rats were hyperplastic and expressed COX-2 protein and mRNA at 8- to 14.7-fold higher levels than control rats. Within hours ZR reduced COX-2 overexpression to threefold that in control rats and reversed the hyperplastic phenotypes. The esophagus of ZD rats treated with celecoxib or indomethacin showed a reduction in cell proliferation and stimulation of apoptosis. NQO treatment resulted in greater incidence of lingual squamous cell carcinomas (74% versus 22%, difference = 52%, 95% confidence interval [CI] = 20% to 80%, P = .015) and greater tumor multiplicity (13.1 versus 4.3, difference = 8.8, 95% CI = 7.0 to 10.6, P = .018) in ZD than ZS rats. Of 23 NQO-treated ZD rats, 39% (9) and 61% (14) harbored esophageal and forestomach tumors, respectively, whereas none of the NQO-treated ZS rats did. Conclusions: COX-2 overexpression accompanies hyperplasia in ZD rats. Increased cell proliferation in NQO-treated ZD rats facilitates the development of tumors at multiple sites. The finding that zinc regulates COX-2 expression in vivo in an animal model may lead to prevention or therapeutic possibilities for upper aerodigestive tract cancer.
引用
收藏
页码:40 / 50
页数:11
相关论文
共 43 条
[1]  
[Anonymous], 2003, CANC FACTS FIG
[2]   The galvanization of biology: A growing appreciation for the roles of zinc [J].
Berg, JM ;
Shi, YG .
SCIENCE, 1996, 271 (5252) :1081-1085
[3]   Modulation of intestinal gene expression by dietary zinc status: Effectiveness of cDNA arrays for expression profiling of a single nutrient deficiency [J].
Blanchard, RK ;
Moore, JB ;
Green, CL ;
Cousins, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13507-13513
[4]  
Chan G, 1999, CANCER RES, V59, P991
[5]  
Cintorino M, 2001, ANTICANCER RES, V21, P4195
[6]   TOXICOLOGICAL AND PATHOLOGICAL APPLICATIONS OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA), A NOVEL ENDOGENOUS MARKER FOR CELL-PROLIFERATION [J].
DIETRICH, DR .
CRITICAL REVIEWS IN TOXICOLOGY, 1993, 23 (01) :77-109
[7]   Zinc deficiency in head and neck cancer patients [J].
Doerr, TD ;
Prasad, AS ;
Marks, SC ;
Beck, FWJ ;
Shamsa, FH ;
Penny, HS ;
Mathog, RH .
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 1997, 16 (05) :418-422
[8]  
FONG LY, 2004, 95 ANN M P, V45
[9]  
Fong LYY, 2003, CANCER RES, V63, P4244
[10]  
Fong LYY, 2003, CANCER RES, V63, P3945